Thursday, 5 January 2017

Clinical Chemistry Analyzer Market is expected to boost over the significant period

Rapid growth in diagnostic market, increasing health care spending and increasing incidence rates of lifestyle disease such as obesity and diabetes are the major driving factors for clinical chemistry analyzer market. In addition, increasing geriatric population, growing awareness for preventive healthcare and rising demand for laboratory automation are some drivers expected to boost the growth of clinical chemistry analyzer market. Clinical chemistry analyzers are most widely used equipments in clinical laboratories for the identification of chronic and fetal disorders.

To request a sample copy or view summary of this report, click the link below:

The clinical chemistry analyzer market is segmented on the basis of test type, products and regions. The product segments is further sub segmented into reagents, analyzers and other products. On the basis of test type the market is segmented into small (400-800 test/H), medium (800-1200 test/H), large (1,200-2,000 Tests/H), and very large (2000 test/H). The reagents segment is divded into controls, calibrators, standards and other reagents. On the basis of test, the market is segmented into metabolic panel, lipid profile, electrolyte panel, specialty chemical tests, thyroid function panel and renal profile or kidney function panel. Basic metabolic panel test segment is the largest test segment of the clinical chemistry analyzer market owing to the increasing demand for preventive medicines and lifestyle induced disorders. Lipid profile test market is expected to show the fastest growth during the forecast period due to increasing prevalence of cardiovascular disorders. The end-use segment includes diagnostic laboratories, research institutes, hospitals and other end users.

Globally, the market is segmented into North America, Europe, Asia Pacific and RoW. North America held the largest market revenue share in the global clinical chemistry analyzer market. Presence of advanced technology, well developed healthcare infrastructure and extensive regulatory framework are the factors attributing for its highest revenue share. On the other hand, the Asia pacific market segment is expected to show the growth at a fast pace on account of increasing demand for automation, rising economic conditions and growing patient awareness for preventive care in this region.

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Web: www.grandviewresearch.com

No comments:

Post a Comment